Stryker Co. (NYSE:SYK) Shares Acquired by North Star Asset Management Inc.

North Star Asset Management Inc. increased its stake in Stryker Co. (NYSE:SYK) by 0.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 99,177 shares of the medical technology company’s stock after purchasing an additional 305 shares during the quarter. Stryker comprises about 1.6% of North Star Asset Management Inc.’s portfolio, making the stock its 14th biggest holding. North Star Asset Management Inc.’s holdings in Stryker were worth $33,745,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of the stock. Burkett Financial Services LLC acquired a new stake in Stryker in the 4th quarter valued at about $25,000. DSM Capital Partners LLC acquired a new stake in Stryker in the 4th quarter valued at about $34,000. Central Pacific Bank Trust Division acquired a new stake in Stryker in the 1st quarter valued at about $39,000. Private Wealth Management Group LLC acquired a new stake in Stryker in the 4th quarter valued at about $40,000. Finally, Northwest Financial Advisors acquired a new stake in Stryker in the 4th quarter valued at about $60,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Buying and Selling at Stryker

In other Stryker news, CFO Glenn S. Boehnlein sold 20,000 shares of the stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $333.00, for a total transaction of $6,660,000.00. Following the transaction, the chief financial officer now owns 2,852 shares in the company, valued at $949,716. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, CFO Glenn S. Boehnlein sold 20,000 shares of the stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $333.00, for a total value of $6,660,000.00. Following the completion of the sale, the chief financial officer now directly owns 2,852 shares of the company’s stock, valued at $949,716. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Ronda E. Stryker sold 190,000 shares of the stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $323.46, for a total value of $61,457,400.00. Following the completion of the sale, the director now directly owns 3,316,608 shares of the company’s stock, valued at $1,072,790,023.68. The disclosure for this sale can be found here. Insiders have sold a total of 210,600 shares of company stock worth $68,330,400 over the last 90 days. Insiders own 5.90% of the company’s stock.

Stryker Trading Up 0.3 %

NYSE:SYK opened at $358.92 on Friday. The stock’s 50 day moving average price is $339.06 and its 200 day moving average price is $341.98. Stryker Co. has a 52 week low of $249.98 and a 52 week high of $364.36. The company has a market capitalization of $136.78 billion, a P/E ratio of 40.97, a P/E/G ratio of 2.78 and a beta of 0.91. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.95 and a current ratio of 1.68.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Tuesday, July 30th. The medical technology company reported $2.81 EPS for the quarter, beating the consensus estimate of $2.79 by $0.02. Stryker had a return on equity of 22.89% and a net margin of 16.12%. The company had revenue of $5.42 billion for the quarter, compared to the consensus estimate of $5.40 billion. During the same quarter last year, the company posted $2.54 earnings per share. The company’s revenue for the quarter was up 8.5% compared to the same quarter last year. On average, research analysts forecast that Stryker Co. will post 12 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Monday, September 30th will be issued a dividend of $0.80 per share. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.20 annualized dividend and a yield of 0.89%. Stryker’s dividend payout ratio (DPR) is presently 36.53%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on SYK shares. UBS Group upped their price target on shares of Stryker from $351.00 to $366.00 and gave the company a “neutral” rating in a report on Wednesday, July 31st. BTIG Research upped their price target on shares of Stryker from $360.00 to $374.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Barclays upped their price objective on shares of Stryker from $374.00 to $402.00 and gave the company an “overweight” rating in a research note on Thursday, August 1st. Morgan Stanley upped their price objective on shares of Stryker from $345.00 to $350.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Finally, Truist Financial reduced their price objective on shares of Stryker from $364.00 to $345.00 and set a “hold” rating for the company in a research note on Thursday, August 1st. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $377.11.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.